Tactical Medicine News Blog – tagged "COVID-19"

COVID COVID-19 PUBLIC HEALTH SARS-COV-2

Micelle Technology Detects Airborne SARS-CoV-2

At the Pacific Northwest National Laboratory, researchers have developed micelle technology that can detect minute amounts of SARS-CoV-2 in the air. This new capability could provide invaluable monitoring systems to detect viral contamination in healthcare facilities and beyon...

COVID COVID-19 GENETICS MEDICINE OREGONSTATE PUBLIC HEALTH SARS-COV-2

mRNA Therapy Prevents COVID Virus Entering Cells

Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is based on mRNA, which has also been put to good use in COVID-19 vaccines. However, in this instance, the delivered mRNA encodes for human angiotensin-converting enzyme 2 (hACE2)...

AWAKE PRONING COVI-PRONE TRIAL COVID-19 COVID19 PRONING UNCATEGORIZED

REBEL Cast Ep110: The COVI-PRONE Trial – Awake Prone Positioning and COVID-19

BASICS OF EM COVID-19 UNCATEGORIZED

REBEL Core Cast – Basics of EM – COVID-19

COVID-19 COVID19 SELECTIVE SEROTONIN REUPTAKE INHIBITORS SSRI UNCATEGORIZED

SSRIs and COVID-19

ANTICOAGULATION CORONAVIRUS COVID-19 COVID19 INSPIRATION TRIAL PULMONARY EMBOLISM SARS-COV-2 UNCATEGORIZED VENOUS THROMBOEMBOLISM

The INSPIRATION Trial: Intermediate Dose Anticoagulation in Critically Ill Patients with COVID-19

ACTION TRIAL ANITCOAGULATION COVID-19 COVID19 THE ACTION TRIAL UNCATEGORIZED

The ACTION Trial: DOACs in Hospitalized Patients with COVID-19

BUDESONIDE CICLESONIDE COVID-19 EM CASES EMERGENCY MEDICINE EVUSHELD FLUVOXAMINE JOURNAL JAM MEDICAL SPECIALTY MOLNUPIRAVIR PAXLOVID REMDESIVIR SOTROVIMAB

JJ 20 Outpatient Medications for COVID-19

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medic...

ANTICOAGULATION COVID-19 COVID19 MICHELLE TRIAL UNCATEGORIZED

The MICHELLE Trial: Anticoagulation Post-Discharge in Patients Hospitalized Secondary to COVID-19